- Home
- TARA vs MGYR Comparison
TARA vs MGYR Comparison
Compare TARA & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- MGYR
- Stock Information
- Founded
- TARA N/A
- MGYR 1922
- Country
- TARA United States
- MGYR United States
- Employees
- TARA N/A
- MGYR N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- MGYR Savings Institutions
- Sector
- TARA Health Care
- MGYR Finance
- Exchange
- TARA Nasdaq
- MGYR Nasdaq
- Market Cap
- TARA 118.1M
- MGYR 98.9M
- IPO Year
- TARA N/A
- MGYR 2006
- Fundamental
- Price
- TARA $3.03
- MGYR $17.50
- Analyst Decision
- TARA Strong Buy
- MGYR
- Analyst Count
- TARA 7
- MGYR 0
- Target Price
- TARA $20.67
- MGYR N/A
- AVG Volume (30 Days)
- TARA 214.2K
- MGYR 2.1K
- Earning Date
- TARA 08-11-2025
- MGYR 07-24-2025
- Dividend Yield
- TARA N/A
- MGYR 2.06%
- EPS Growth
- TARA N/A
- MGYR 35.31
- EPS
- TARA N/A
- MGYR 1.57
- Revenue
- TARA N/A
- MGYR $35,533,000.00
- Revenue This Year
- TARA N/A
- MGYR N/A
- Revenue Next Year
- TARA N/A
- MGYR N/A
- P/E Ratio
- TARA N/A
- MGYR $11.14
- Revenue Growth
- TARA N/A
- MGYR 18.29
- 52 Week Low
- TARA $1.60
- MGYR $12.10
- 52 Week High
- TARA $10.48
- MGYR $19.04
- Technical
- Relative Strength Index (RSI)
- TARA 44.29
- MGYR 62.42
- Support Level
- TARA $3.06
- MGYR $17.10
- Resistance Level
- TARA $3.33
- MGYR $17.49
- Average True Range (ATR)
- TARA 0.17
- MGYR 0.13
- MACD
- TARA -0.01
- MGYR 0.02
- Stochastic Oscillator
- TARA 4.65
- MGYR 98.96
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.